Report cover image

Saudi Arabia Veterinary Vaccine Market, By Type (Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines); By Disease (Poultry, Livestock, Companion Animals, Aquaculture); By Technology (Live Attenuated Vaccines, Inactivated

Publisher BlueWeave Consulting
Published Sep 18, 2023
Length 200 Pages
SKU # BLWC18285347

Description

Saudi Arabia Veterinary Vaccine Market, By Type (Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines); By Disease (Poultry, Livestock, Companion Animals, Aquaculture); By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines); By Route of Administration (Oral, Parenteral, Topical); By End Use (Hospitals, Clinics), Competitive Landscape & Forecast, 2019–2029


Saudi Arabia Veterinary Vaccine Market Size Set to Grow at Significant CAGR of 8.69% to Reach USD 376.72 Million by 2029

Saudi Arabia veterinary vaccine market is flourishing due to an increasing focus on animal health and welfare, rising livestock production, government initiatives to control animal diseases, and growing awareness among farmers about the importance of vaccination to prevent diseases and ensure better productivity.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Saudi Arabia veterinary vaccine market size at USD 228.53 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Saudi Arabia veterinary vaccine market size to grow at a significant CAGR of 8.69% reaching a value of USD 376.72 million by 2029. The increased need for animal health products, such as vaccinations, owing to the livestock and companion animal sectors, is one of the main reasons fueling the growth of the Saudi Arabian veterinary vaccine market. The necessity of preventative healthcare being better understood by pet owners and livestock farmers contributed to the market's expansion. Also, improvements in biotechnology and veterinary science resulted in the creation of more potent and tailored vaccinations for a variety of animal species. The government's emphasis on improving the infrastructure for animal healthcare was also a major growth factor for the market.

Saudi Arabia Veterinary Vaccine Market – Overview

Veterinary vaccines are essential tools used to prevent and control infectious diseases in animals. Designed to stimulate an immune response, they protect animals from various pathogens, such as viruses and bacteria. These vaccines are crucial in maintaining animal health, reducing transmission of diseases to humans, and ensuring food safety. Vaccination programs are tailored to specific species and regional disease risks. Commonly administered to livestock, pets, and wildlife, veterinary vaccines play a vital role in safeguarding animal populations, supporting sustainable agriculture, and promoting public health. Continuous research and advancements in vaccine technology are continually improving their effectiveness and expanding their applications.

Impact of COVID-19 on Saudi Arabia Veterinary Vaccine Market

The COVID-19 pandemic significantly impacted the Saudi Arabia veterinary vaccines market. As restrictions and economic uncertainties prevailed, demand for animal healthcare products, including vaccines, experienced fluctuations. With limitations on movement and gatherings, veterinary clinics faced reduced footfall, affecting vaccine administration. Also, disruptions in supply chains posed challenges in accessing and distributing vaccines. However, as the pandemic subsided, the market gradually recovered, driven by the resumption of economic activities and increased awareness of animal health. The long-term impact remains subject to how the nation addresses any potential resurgence of the virus and sustains its economic recovery.

Saudi Arabia Veterinary Vaccine Market – By Technology

By technology, Saudi Arabia veterinary vaccines market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Recombinant Vaccines segments. The live attenuated vaccines segment is the largest in the Saudi Arabia veterinary vaccines market by technology. The segment represents a significant portion of the market and involves vaccines containing weakened pathogens. Other segments include inactivated vaccines, toxoid vaccines, and recombinant vaccines, catering to various specific needs in the veterinary industry. However, live attenuated vaccines stand out as the most prominent segment, likely due to their effectiveness in providing immunity to a wide range of animal species. The demand for these vaccines reflects the importance of preventing and controlling infectious diseases among animals in the region.

Competitive Landscape

Saudi Arabia veterinary vaccines market is fiercely competitive. Major companies in the market include Bayer AG, Sanofi, Pfizer Inc, GSK plc, Merck & Co., Inc., Ceva, Cargill, Incorporated, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, and Zoetis. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Saudi Arabia veterinary vaccines market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Saudi Arabia Veterinary Vaccine Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Saudi Arabia Veterinary Vaccine Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

200 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Saudi Arabia Veterinary Vaccine Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing research activities associated with veterinary-animal vaccines
3.2.1.2. Increasing pet ownership
3.2.2. Restraints
3.2.2.1. Side-effects of veterinary-animal vaccines
3.2.3. Opportunities
3.2.3.1. Increasing strategic developments associated with veterinary-animal vaccines
3.2.4. Challenges
3.2.4.1. Inadequate surveillance and reporting systems
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Saudi Arabia Veterinary Vaccine Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Type
4.2.1.1. Poultry Vaccines
4.2.1.2. Livestock Vaccines
4.2.1.3. Companion Animal Vaccines
4.2.1.4. Aquaculture Vaccines
4.2.1.5. Other Animal Vaccines
4.2.2. By Disease
4.2.2.1. Poultry
4.2.2.2. Livestock
4.2.2.3. Companion Animals
4.2.2.4. Aquaculture
4.2.3. By Technology
4.2.3.1. Live Attenuated Vaccines
4.2.3.2. Inactivated Vaccines
4.2.3.3. Toxoid Vaccines
4.2.3.4. Recombinant Vaccines
4.2.3.5. Other Vaccines
4.2.4. By Route of Administration
4.2.4.1. Oral
4.2.4.2. Parenteral
4.2.4.3. Topical
4.2.5. By End Use
4.2.5.1. Hospitals
4.2.5.2. Clinics
5. Competitive Landscape
5.1. List of Key Players and Their Offerings
5.2. Saudi Arabia Veterinary Vaccine Company Market Share Analysis, 2022
5.3. Competitive Benchmarking, By Operating Parameters
5.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
6. Impact of Covid-19 on Saudi Arabia Veterinary Vaccine Market
7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
7.1. Bayer AG
7.2. Sanofi
7.3. Pfizer Inc.
7.4. GSK plc
7.5. Merck & Co., Inc.
7.6. Ceva
7.7. Cargill, Incorporated
7.8. Boehringer Ingelheim International GmbH.
7.9. Takeda Pharmaceutical Company Limited
7.10. Zoetis
7.11. Other Prominent Players
8. Key Strategic Recommendations
9. Research Methodology
9.1. Qualitative Research
9.1.1. Primary & Secondary Research
9.2. Quantitative Research
9.3. Market Breakdown & Data Triangulation
9.3.1. Secondary Research
9.3.2. Primary Research
9.4. Breakdown of Primary Research Respondents, By Region
9.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Saudi Arabia Veterinary Vaccine Segmentation
Figure 2 Saudi Arabia Veterinary Vaccine Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Saudi Arabia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 5 Saudi Arabia Veterinary Vaccine Market Share, By Type, By Value, 2019–2029
Figure 6 Saudi Arabia Veterinary Vaccine Market Share, By Disease, By Value, 2019–2029
Figure 7 Saudi Arabia Veterinary Vaccine Market Share, By Technology, By Value, 2019–2029
Figure 8 Saudi Arabia Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 9 Saudi Arabia Veterinary Vaccine Market Share, By End Use, By Value, 2019–2029
List of Tables
Table 1 Saudi Arabia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 2 Saudi Arabia Veterinary Vaccine Market Size, By Type, By Value, 2019–2029
Table 3 Saudi Arabia Veterinary Vaccine Market Size, By Disease, By Value, 2019–2029
Table 4 Saudi Arabia Veterinary Vaccine Market Size, By Technology, By Value, 2019–2029
Table 5 Saudi Arabia Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 6 Saudi Arabia Veterinary Vaccine Market Size, By End Use, By Value, 2019–2029
Table 7 Bayer AG Company Overview
Table 8 Bayer AG Financial Overview
Table 9 Sanofi Company Overview
Table 10 Sanofi Financial Overview
Table 11 Pfizer Inc. Company Overview
Table 12 Pfizer Inc. Financial Overview
Table 13 GSK plc Company Overview
Table 14 GSK plc Financial Overview
Table 15 Merck & Co., Inc. Company Overview
Table 16 Merck & Co., Inc. Financial Overview
Table 17 Ceva Company Overview
Table 18 Ceva Financial Overview
Table 19 Cargill, Incorporated Company Overview
Table 20 Cargill, Incorporated Financial Overview
Table 21 Boehringer Ingelheim International GmbH. Company Overview
Table 22 Boehringer Ingelheim International GmbH. Financial Overview
Table 23 Takeda Pharmaceutical Company Limited Company Overview
Table 24 Takeda Pharmaceutical Company Limited Financial Overview
Table 25 Zoetis Company Overview
Table 26 Zoetis Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us